![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België
![Most Active Swiss Domestic Bonds 21.05.2021 – Credit Suisse Guernsey, Aryzta, MSC Cruises, Swisscom, Basilea Pharma – Financial Markets Blog – by Zuberbühler Associates AG Most Active Swiss Domestic Bonds 21.05.2021 – Credit Suisse Guernsey, Aryzta, MSC Cruises, Swisscom, Basilea Pharma – Financial Markets Blog – by Zuberbühler Associates AG](https://zuberbuehlerassociates.files.wordpress.com/2021/05/domestic-bonds-2021-05-22_3.png?w=387)
Most Active Swiss Domestic Bonds 21.05.2021 – Credit Suisse Guernsey, Aryzta, MSC Cruises, Swisscom, Basilea Pharma – Financial Markets Blog – by Zuberbühler Associates AG
![Teva präsentiert neue Analysen zu AJOVY® (Fremanezumab) und jüngste Daten zu COPAXONE® (Injektionslösung Glatirameracetat) auf dem Kongress der Europäischen Akademie für Neurologie | Business Wire Teva präsentiert neue Analysen zu AJOVY® (Fremanezumab) und jüngste Daten zu COPAXONE® (Injektionslösung Glatirameracetat) auf dem Kongress der Europäischen Akademie für Neurologie | Business Wire](https://mms.businesswire.com/media/20200522005411/de/739014/22/teva_RGB_JPEG.jpg)